Thermo Fisher (NYSE: TMO) CFO details stock and option stake

Rhea-AI Filing Summary

Thermo Fisher Scientific Inc. senior vice president and CFO James Meyer filed an initial ownership statement reporting his equity stake in the company. The filing shows direct ownership of 5,841.4637 shares of common stock and an additional 50.03 shares held indirectly through a 401(k) plan.

He also reports multiple stock option awards on Thermo Fisher common stock with exercise prices ranging from 430.7300 to 635.1000 per share and expiration dates between 2028 and 2035. Individual grants include, for example, 6,851 underlying shares at an exercise price of 513.6800 and 3,598 underlying shares at an exercise price of 430.7300, reflecting substantial unexercised option-based exposure.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Meyer James

(Last) (First) (Middle)

168 THIRD AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2026

3. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. Vice President & CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,841.4637	D
Common Stock	50.03	I	by 401k

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	02/23/2028	Common Stock	920	$458.81	D
Stock Option (Right to Buy)	(2)	11/01/2028	Common Stock	223	$635.1	D
Stock Option (Right to Buy)	(3)	02/23/2030	Common Stock	579	$528.58	D
Stock Option (Right to Buy)	(4)	02/22/2031	Common Stock	715	$548.4	D
Stock Option (Right to Buy)	(5)	02/22/2031	Common Stock	1,713	$548.4	D
Stock Option (Right to Buy)	(6)	02/21/2032	Common Stock	424	$552.85	D
Stock Option (Right to Buy)	(7)	02/21/2032	Common Stock	1,929	$552.85	D
Stock Option (Right to Buy)	(8)	02/19/2035	Common Stock	2,777	$530.86	D
Stock Option (Right to Buy)	(9)	07/10/2035	Common Stock	3,598	$430.73	D
Stock Option (Right to Buy)	(10)	02/25/2035	Common Stock	6,851	$513.68	D

Explanation of Responses:

1. The options vested in four equal installments on February 23, 2022, 2023, 2024, and 2025.

2. The options vested in four equal installments on November 1, 2022, 2023, 2024, and 2025.

3. The options vested in four equal installments on February 28, 2023, 2024, 2025, and 2026.

4. The options vest in four equal annual installments. Three-quarters of the options vested on February 22, 2024, 2025, and 2026, and the remaining one-quarter will vest on February 22, 2027.

5. The options vest in four equal annual installments. Three-quarters of the options vested on February 28, 2024, 2025, and 2026, and the remaining one-quarter will vest on February 28, 2027.

6. The options vest in four equal annual installments. Two-quarters of the options vested on February 28, 2025 and 2026, and the remaining two-quarters will vest on February 28, 2027 and 2028.

7. The options vest in four equal annual installments. Two-quarters of the options vested on February 28, 2025 and 2026, and the remaining two-quarters will vest on February 28, 2027 and 2028.

8. The options vest in four equal annual installments. One-quarter of the options vested on February 28, 2026, and the remaining three-quarters will vest on February 28, 2027, 2028 and 2029.

9. The options vest in four equal annual installments on July 10, 2026, 2027, 2028 and 2029.

10. The options vest in four equal annual installments on February 28, 2027, 2028, 2029 and 2030.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Melodie T. Morin, Attorney-in-Fact for James Meyer	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Thermo Fisher (TMO) CFO James Meyer report in this Form 3?

James Meyer reports his initial ownership of Thermo Fisher equity, including common shares and stock options. The statement lists 5,841.4637 common shares held directly, 50.03 shares via a 401(k), and several option grants over Thermo Fisher common stock with varying exercise prices and expirations.

How many Thermo Fisher (TMO) common shares does the CFO hold directly and indirectly?

The CFO reports 5,841.4637 Thermo Fisher common shares held directly. He also reports an additional 50.03 common shares held indirectly through a 401(k) plan, giving investors a view of his direct and retirement-plan-based equity exposure as of this ownership statement.

What stock option positions does the Thermo Fisher (TMO) CFO disclose?

James Meyer discloses multiple stock option awards on Thermo Fisher common stock. These include grants such as 6,851 underlying shares at a 513.6800 exercise price and 3,598 underlying shares at 430.7300, with option expiration dates stretching from 2028 through 2035.

Are there any buy or sell transactions in this Thermo Fisher (TMO) Form 3?

No buy or sell transactions are reported in this Form 3. All entries are categorized as holdings, showing existing common stock and option positions, rather than new purchases, sales, exercises, or dispositions during the period covered by the ownership report.

How do the Thermo Fisher (TMO) CFO’s options vest according to the footnotes?

The footnotes state that various option grants vest in four equal annual installments. Some options are already fully vested, while others vest over future dates, including schedules extending through February 2030, reflecting a multi-year compensation and retention structure.

What are the exercise price range and expirations of the Thermo Fisher (TMO) CFO’s options?

The reported stock options carry exercise prices from 430.7300 to 635.1000 per share. Option expiration dates run from February 23, 2028, through July 10, 2035, indicating long-dated incentives aligned with Thermo Fisher’s longer-term performance horizon.